UFP Technologies (STU:UFP) EBIT: €79.6 Mil (TTM As of Mar. 2026)


STU:UFP UFP Technologies Inc STU:UFP
96 GF Score
Price €219.40
GF Value €235.06
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is UFP Technologies EBIT?

UFP Technologies STU:UFP +3.69% 96 EBIT is €79.6 Mil as of Mar. 2026. GuruFocus rates STU:UFP with a GF Score™ of 96/100 and a GF Value™ of €235.06 (Fairly Valued). The stock has 5 warning signs investors should review.

UFP Technologies's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €20.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €79.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. UFP Technologies's annualized ROC % for the quarter that ended in Mar. 2026 was 12.75%. UFP Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 41.45%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. UFP Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 4.32%.


UFP Technologies  (STU:UFP) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

UFP Technologies's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=80.76 * ( 1 - 19.04% )/( (506.768 + 518.86)/ 2 )
=65.383296/512.814
=12.75 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

UFP Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=80.772/( ( (83.682 + max(100.829, 0)) + (83.541 + max(121.657, 0)) )/ 2 )
=80.772/( ( 184.511 + 205.198 )/ 2 )
=80.772/194.8545
=41.45 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(70.809 + 74.175 + 4.8) - (35.331 + 3.621 + 10.003)
=100.829

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(85.26 + 81.295 + 6.567) - (47.463 + 4.002 + 0)
=121.657

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

UFP Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=79.581/1841.282
=4.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


UFP Technologies EBIT Related Terms


UFP Technologies EBIT Historical Data

* Premium members only.

The historical data trend for UFP Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

UFP Technologies EBIT Chart

UFP Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.80 52.37 52.77 77.44 78.84

UFP Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.36 21.07 19.99 18.34 20.19

STU:UFP vs PRCT, NEOG, NVCR: EBIT Comparison

For the Medical Devices subindustry, UFP Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UFP Technologies EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, UFP Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where UFP Technologies's EV-to-EBIT falls into.


STU:UFP
96GF Score
UFP Technologies Inc STU:UFP
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

UFP Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €79.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €79.6 Mil mean?
UFP Technologies (STU:UFP) has a EBIT of €79.6 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on UFP Technologies.
Is UFP Technologies' EBIT too high?
UFP Technologies' current EBIT is €79.6 Mil. Overall, UFP Technologies has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does UFP Technologies' EBIT compare to PRCT and NEOG?
UFP Technologies' EBIT of €79.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on UFP Technologies. UFP Technologies's current EBIT is €79.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is UFP Technologies stock overvalued right now?
Based on GuruFocus' analysis, UFP Technologies (STU:UFP) is currently considered Fairly Valued. The stock's GF Value™ is €235.06, compared to a current price of €219.40 — trading 6.7% below its estimated fair value. The current EBIT is €79.6 Mil. UFP Technologies' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For UFP Technologies (STU:UFP), the current EBIT is €79.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is UFP Technologies (STU:UFP) Overvalued in 2026?

Based on GuruFocus' analysis, UFP Technologies stock appears to be undervalued. The current stock price of €219.40 is trading 6.7% below its estimated GF Value™ of €235.06. GuruFocus considers UFP Technologies to be Fairly Valued.

Key valuation signals for STU:UFP:

  • EBIT: €79.6 Mil
  • GF Value™: €235.06 vs. price of €219.40 (6.7% below fair value)
  • GF Score™: 96/100 with 5 warning signs

No single metric tells the full story. See the STU:UFP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


UFP Technologies Business Description

Other Exchanges UFPT:USAUFP:Germany
Address 100 Hale Street, Newburyport, MA, USA, 01950-3504
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
96GF Score

Get the complete analysis for STU:UFP

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€219.40
Price
€235.06
GF Value